Dakshidin Stock Price, News & Analysis
Company Description
Dakshidin (OTC Link: DKSC) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $447.8K.
DKSC stock has gained 0.0% over the past year. Shares last traded at $0.0005.
This page provides a comprehensive overview of DKSC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Dakshidin (DKSC) stock last traded at $0.0005. At a market capitalization of $447.8K, DKSC is classified as a micro-cap stock with approximately 4.4B shares outstanding.
Latest News
Dakshidin has 6 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 0 with negative movement. Key topics include acquisition, partnership. View all DKSC news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Dakshidin (DKSC) currently stands at 300.0 thousand shares, down 0.0% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 614.2%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Dakshidin (DKSC) currently stands at 1.0 days, down 93.3% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
DKSC Company Profile & Sector Positioning
Dakshidin (DKSC) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing DKSC often look at related companies in the same sector, including Gelstat Corp (GSAC), Aequus Pharmaceu (AQSZF), Multicorp Inter (MCIC), Greater Cannabis (GCAN), and Global Hemp Group Inc (GBHPF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DKSC's relative position within its industry.